Empirical Wealth Management
ORKA icon

Empirical Wealth Management’s Oruka Therapeutics ORKA Stock Holding History

Empirical Wealth Management’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.65M Buy
19,855
+543
+3% +$51.2K 0.02% 329
2026
Q2 		$1.84M Buy
19,312
+1,083
+6% +$72.2K 0.03% 286
2026
Q1 		$894K Buy
18,229
+2,823
+18% +$98.1K 0.02% 381
2025
Q4 		$467K Hold
15,406
– – 0.01% 540
2025
Q3 		$296K Buy
+15,406
New +$228K 0.01% 618

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $109B AUM 51.53% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Empirical Wealth Management's ORKA Position: Q3 2026 in Review

Empirical Wealth Management increased its Oruka Therapeutics (ORKA) stake by 2.8% in Q3 2026, buying an estimated $51.2K and bringing the position to 19,855 shares worth $1.65M. The position accounts for 0.02% of the portfolio, ranked #329.

Empirical Wealth Management first reported a position in ORKA in Q3 2025 and has held it in 5 quarters since. The position peaked at $1.84M in Q2 2026. 110 funds tracked by Wall St. Rank hold ORKA as of Q3 2026.

  • Empirical Wealth Management held 19,855 shares of Oruka Therapeutics worth $1.65M as of Q3 2026.
  • Empirical Wealth Management bought 543 Oruka Therapeutics shares in Q3 2026, an estimated $51.2K.
  • Oruka Therapeutics made up 0.02% of Empirical Wealth Management's portfolio in Q3 2026, its #329 holding.
  • Empirical Wealth Management first reported a position in Oruka Therapeutics in Q3 2025 and has held it in 5 quarters since.
  • Empirical Wealth Management's Oruka Therapeutics position peaked at $1.84M in Q2 2026.
  • 110 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q3 2026.

Based on Empirical Wealth Management's 13F filing for Q3 2026, filed 27 Oct 2026.